Racura Oncology Ltd has released a press release.
Racura raised $34.3m to Advance Three Oncology Trials
Earlier from Racura Oncology
- Emerging Companies Specialist Invests in Racura
- Racura Enters Underwriting Agreement for Options
- Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial
- CPACS Trial Cleared to Escalate to Next RC220 Dose Level